139 related articles for article (PubMed ID: 35039939)
1. The Eastern Cooperative Oncology Group Performance Status as a prognostic factor of stage I-III colorectal cancer surgery for elderly patients: a multi-institutional retrospective analysis.
Hanaoka M; Hino H; Shiomi A; Kagawa H; Manabe S; Yamaoka Y; Kato S; Yamauchi S; Kinugasa Y; Sugihara K
Surg Today; 2022 Jul; 52(7):1081-1089. PubMed ID: 35039939
[TBL] [Abstract][Full Text] [Related]
2. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
[TBL] [Abstract][Full Text] [Related]
3. Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients.
Chen D; Wen X; Song YS; Rhee YY; Lee TH; Cho NY; Han SW; Kim TY; Kang GH
Clin Epigenetics; 2016; 8():36. PubMed ID: 27051466
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
5. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
6. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
[TBL] [Abstract][Full Text] [Related]
7. The preoperative geriatric nutritional risk index (GNRI) is an independent prognostic factor in elderly patients underwent curative resection for colorectal cancer.
Hayama T; Hashiguchi Y; Ozawa T; Watanabe M; Fukushima Y; Shimada R; Nozawa K; Matsuda K; Fujii S; Fukagawa T
Sci Rep; 2022 Mar; 12(1):3682. PubMed ID: 35256659
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Utility of Apical Lymph Node Metastasis in Patients With Left-sided Colorectal Cancer.
Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Yamaguchi S
In Vivo; 2020; 34(5):2981-2989. PubMed ID: 32871841
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
[TBL] [Abstract][Full Text] [Related]
12. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for recurrence in elderly patients with stage II colorectal cancer: a multicenter retrospective study.
Yagyu T; Yamamoto M; Tanio A; Hara K; Sugezawa K; Uejima C; Kihara K; Tatebe S; Kurisu Y; Shibata S; Yamamoto T; Nishie H; Shiota S; Saito H; Naka T; Sugamura K; Katano K; Fujiwara Y
BMC Cancer; 2022 Apr; 22(1):390. PubMed ID: 35410196
[TBL] [Abstract][Full Text] [Related]
14. Horizontal spread of pericolic lymph node metastasis as a prognostic factor for recurrence in Stage III colorectal cancer.
Sasaki T; Shigeta K; Okabayashi K; Tsuruta M; Seishima R; Matsui S; Kitagawa Y
Colorectal Dis; 2021 Jun; 23(6):1370-1378. PubMed ID: 33590648
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
[TBL] [Abstract][Full Text] [Related]
16. Effect of abdominal aortic calcification on the prognosis and recurrence of colorectal cancer stages II-III: A retrospective cohort study.
Imaoka K; Shimomura M; Shimizu W; Akabane S; Ohira M; Imaoka Y; Yoshinaka H; Ono K; Mochizuki T; Matsubara K; Bekki T; Hattori M; Ohdan H
Int J Colorectal Dis; 2023 Jan; 38(1):21. PubMed ID: 36680603
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio may predict relapse free survival and overall survival in patients with stage II & III colorectal carcinoma.
Zekri J; Ahmad I; Fawzy E; Elkhodary TR; Al-Gahmi A; Hassouna A; El Sayed ME; Ur Rehman J; Karim SM; Bin Sadiq B
Hepatogastroenterology; 2015; 62(138):291-4. PubMed ID: 25916051
[TBL] [Abstract][Full Text] [Related]
18. Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.
Li Q; Liang L; Jia H; Li X; Xu Y; Zhu J; Cai S
Oncotarget; 2016 Nov; 7(44):72290-72299. PubMed ID: 27474167
[TBL] [Abstract][Full Text] [Related]
19. Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.
Sugawara K; Kawaguchi Y; Nomura Y; Koike D; Nagai M; Tanaka N
World J Surg; 2017 Jan; 41(1):295-305. PubMed ID: 27464912
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic factors and applicability of Kohne's prognostic groups in patients with metastatic colorectal cancer treated with first-line irinotecan or oxaliplatin-based chemotherapy.
Díaz R; Aparicio J; Gironés R; Molina J; Palomar L; Segura A; Montalar J
Clin Colorectal Cancer; 2005 Sep; 5(3):197-202. PubMed ID: 16197623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
